Learn More
The prevalence of Alzheimer's disease (AD) is rising alarmingly as the average age of our population increases. There is no treatment to halt or slow the pathology responsible for AD, however, new drugs are promising to reduce the rate of progression. On the other hand, the efficacy of these new medications critically depends on our ability to diagnose AD(More)
Acknowledgments We extend our deepest appreciation to Fred Kent, Kathy Madden, Steve Davies and the Project for Public Spaces, and to William H. Whyte, who inspired this work. We thank Techneos Systems for providing their mobile survey software. We also thank and two anonymous reviewers for their helpful comments on early drafts of this paper. We are also(More)
  • 1